Correlation Between Arrowhead Pharmaceuticals and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Crispr Therapeutics AG, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Crispr Therapeutics.
Diversification Opportunities for Arrowhead Pharmaceuticals and Crispr Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Arrowhead and Crispr is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Arrowhead Pharmaceuticals and Crispr Therapeutics
Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 1.01 times more return on investment than Crispr Therapeutics. However, Arrowhead Pharmaceuticals is 1.01 times more volatile than Crispr Therapeutics AG. It trades about 0.31 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.01 per unit of risk. If you would invest 2,118 in Arrowhead Pharmaceuticals on August 26, 2025 and sell it today you would earn a total of 2,263 from holding Arrowhead Pharmaceuticals or generate 106.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arrowhead Pharmaceuticals vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Arrowhead Pharmaceuticals |
| Crispr Therapeutics |
Arrowhead Pharmaceuticals and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arrowhead Pharmaceuticals and Crispr Therapeutics
The main advantage of trading using opposite Arrowhead Pharmaceuticals and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Arrowhead Pharmaceuticals vs. Vaxcyte | Arrowhead Pharmaceuticals vs. Crispr Therapeutics AG | Arrowhead Pharmaceuticals vs. PTC Therapeutics | Arrowhead Pharmaceuticals vs. Arcellx |
| Crispr Therapeutics vs. Vaxcyte | Crispr Therapeutics vs. Arrowhead Pharmaceuticals | Crispr Therapeutics vs. Krystal Biotech | Crispr Therapeutics vs. PTC Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |